Therapeutic potential of mitotic interaction between the nucleoporin Tpr and aurora kinase A

References

• Nigg EA, Raff JW. Centrioles, centrosomes, and cilia in health and disease. Cell 2009; 139: 663–78; PMID:19914163; http://dx.doi.org/10.1016/j.cell.2009.10.036
   PubMed Web of Science ®Google Scholar
• Bettencourt-Dias M, Glover DM. Centrosome biogenesis and function: centrosomics brings new understanding. Nat Rev Mol Cell Biol 2007; 8: 451–63; PMID:17505520; http://dx.doi.org/10.1038/nrm2180
   PubMed Web of Science ®Google Scholar
• Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M. Proteomic characterization of the human centrosome by protein correlation profiling. Nature 2003; 426: 570–4; PMID:14654843; http://dx.doi.org/10.1038/nature02166
   PubMed Web of Science ®Google Scholar
• Jakobsen L, Vanselow K, Skogs M, Toyoda Y, Lundberg E, Poser I, Falkenby LG, Bennetzen M, Westendorf J, Nigg EA., et al. Novel asymmetrically localizing components of human centrosomes identified by complementary proteomics methods. EMBO J 2011; 30: 1520–35; PMID:21399614; http://dx.doi.org/10.1038/emboj.2011.63
   PubMed Web of Science ®Google Scholar
• Fernandez-Martinez J, Rout MP. A jumbo problem: mapping the structure and functions of the nuclear pore complex. Curr Opin Cell Biol 2012; 24: 92–9; PMID:22321828; http://dx.doi.org/10.1016/j.ceb.2011.12.013
   PubMed Web of Science ®Google Scholar
• Tran EJ, Wente SR. Dynamic nuclear pore complexes: life on the edge. Cell 2006; 125: 1041–53; PMID:16777596; http://dx.doi.org/10.1016/j.cell.2006.05.027
   PubMed Web of Science ®Google Scholar
• Simon DN, Rout MP. Cancer and the nuclear pore complex. Adv Exp Med Biol 2014; 773: 285–307; PMID:24563353; http://dx.doi.org/10.1007/978-1-4899-8032-8_13
   PubMed Web of Science ®Google Scholar
• Funasaka T, Wong RW. The role of nuclear pore complex in tumor microenvironment and metastasis. Cancer Metastasis Rev 2011; 30: 239–51; PMID:21298575; http://dx.doi.org/10.1007/s10555-011-9287-y
   PubMed Web of Science ®Google Scholar
• Chatel G, Fahrenkrog B. Nucleoporins: leaving the nuclear pore complex for a successful mitosis. Cell Signal 2011; 23: 1555–62; PMID:21683138; http://dx.doi.org/10.1016/j.cellsig.2011.05.023
   PubMed Web of Science ®Google Scholar
• Nakano H, Funasaka T, Hashizume C, Wong RW. Nucleoporin translocated promoter region (Tpr) associates with dynein complex, preventing chromosome lagging formation during mitosis. J Biol Chem 2010; 285: 10841–9; PMID:20133940; http://dx.doi.org/10.1074/jbc.M110.105890
   PubMed Web of Science ®Google Scholar
• Nezi L, Rancati G, De Antoni A, Pasqualato S, Piatti S, Musacchio A. Accumulation of Mad2-Cdc20 complex during spindle checkpoint activation requires binding of open and closed conformers of Mad2 in saccharomyces cerevisiae. J Cell Biol 2006; 174: 39–51; PMID:16818718; http://dx.doi.org/10.1083/jcb.200602109
   PubMed Web of Science ®Google Scholar
• Peschard P, Park M. From Tpr-met to met, tumorigenesis and tubes. Oncogene 2007; 26: 1276–85; PMID:17322912; http://dx.doi.org/10.1038/sj.onc.1210201
   PubMed Web of Science ®Google Scholar
• Frosst P, Guan T, Subauste C, Hahn K, Gerace L. Tpr is localized within the nuclear basket of the pore complex and has a role in nuclear protein export. J Cell Biol 2002; 156: 617–30; PMID:11839768; http://dx.doi.org/10.1083/jcb.200106046
   PubMed Web of Science ®Google Scholar
• Krull S, Thyberg J, Bjorkroth B, Rackwitz HR, Cordes VC. Nucleoporins as components of the nuclear pore complex core structure and Tpr as the architectural element of the nuclear basket. Mol Biol Cell 2004; 15: 4261–77; PMID:15229283; http://dx.doi.org/10.1091/mbc.E04-03-0165
   PubMed Web of Science ®Google Scholar
• Mitchell PJ, Cooper CS. Nucleotide sequence analysis of human tpr cDNA clones. Oncogene 1992; 7: 383–8; PMID:1549355
   PubMed Web of Science ®Google Scholar
• Cordes VC, Reidenbach S, Rackwitz HR, Franke WW. Identification of protein p270/tpr as a constitutive component of the nuclear pore complex-attached intranuclear filaments. J Cell Biol 1997; 136: 515–29; PMID:9024684; http://dx.doi.org/10.1083/jcb.136.3.515
   PubMed Web of Science ®Google Scholar
• Schweizer N, Ferras C, Kern DM, Logarinho E, Cheeseman IM, Maiato H. Spindle assembly checkpoint robustness requires tpr-mediated regulation of Mad1/Mad2 proteostasis. J Cell Biol 2013; 203: 883–93; PMID:24344181; http://dx.doi.org/10.1083/jcb.201309076
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bravo V, Maciejowski J, Corona J, Buch HK, Collin P, Kanemaki MT, Shah JV, Jallepalli PV. Nuclear pores protect genome integrity by assembling a premitotic and mad1-dependent anaphase inhibitor. Cell 2014; 156: 1017–31; PMID:24581499; http://dx.doi.org/10.1016/j.cell.2014.01.010
   PubMed Web of Science ®Google Scholar
• Buchwalter A, Hetzer MW. Nuclear pores set the speed limit for mitosis. Cell 2014; 156: 868–9; PMID:24581486; http://dx.doi.org/10.1016/j.cell.2014.02.004
   PubMed Web of Science ®Google Scholar
• Muller H, Schmidt D, Steinbrink S, Mirgorodskaya E, Lehmann V, Habermann K, Dreher F, Gustavsson N, Kessler T, Lehrach H., et al. Proteomic and functional analysis of the mitotic drosophila centrosome. EMBO J 2010; 29: 3344–57; PMID:20818332; http://dx.doi.org/10.1038/emboj.2010.210
   PubMed Web of Science ®Google Scholar
• Pfau SJ, Amon A. Chromosomal instability and aneuploidy in cancer: from yeast to man. EMBO Rep 2012; 13: 515–27; PMID:22614003; http://dx.doi.org/10.1038/embor.2012.65
   PubMed Web of Science ®Google Scholar
• Lee SH, Sterling H, Burlingame A, McCormick F. Tpr directly binds to Mad1 and Mad2 and is important for the Mad1-Mad2-mediated mitotic spindle checkpoint. Genes Dev 2008; 22: 2926–31; PMID:18981471; http://dx.doi.org/10.1101/gad.1677208
   PubMed Web of Science ®Google Scholar
• Funasaka T, Tsuka E, Wong RW. Regulation of autophagy by nucleoporin tpr. Sci Rep 2012; 2: 878; PMID:23170199; http://dx.doi.org/10.1038/srep00878
   PubMed Web of Science ®Google Scholar
• Manfredi MG, Ecsedy JA, Meetze KA, Balani SK, Burenkova O, Chen W, Galvin KM, Hoar KM, Huck JJ, LeRoy PJ., et al. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of aurora a kinase. Proc Natl Acad Sci U S A 2007; 104: 4106–11; PMID:17360485; http://dx.doi.org/10.1073/pnas.0608798104
   PubMed Web of Science ®Google Scholar
• Marxer M, Ma HT, Man WY, Poon RY. p53 deficiency enhances mitotic arrest and slippage induced by pharmacological inhibition of aurora kinases. Oncogene 2014; 33: 3550–60; PMID:23955083; http://dx.doi.org/10.1038/onc.2013.325
   PubMed Web of Science ®Google Scholar
• Manfredi MG, Ecsedy JA, Chakravarty A, Silverman L, Zhang M, Hoar KM, Stroud SG, Chen W, Shinde V, Huck JJ., et al. Characterization of alisertib (MLN8237), an investigational small-molecule inhibitor of aurora a kinase using novel in vivo pharmacodynamic assays. Clin Cancer Res 2011; 17: 7614–24; PMID:22016509; http://dx.doi.org/10.1158/1078-0432.CCR-11-1536
   PubMed Web of Science ®Google Scholar
• Kesisova IA, Nakos KC, Tsolou A, Angelis D, Lewis J, Chatzaki A, Agianian B, Giannis A, Koffa MD. Tripolin A, a novel small-molecule inhibitor of aurora a kinase, reveals new regulation of HURP's distribution on microtubules. PLoS One 2013; 8: e58485; PMID:23516487; http://dx.doi.org/10.1371/journal.pone.0058485
   PubMed Web of Science ®Google Scholar
• Gautschi O, Heighway J, Mack PC, Purnell PR, Lara PN, Jr., Gandara DR. Aurora kinases as anticancer drug targets. Clin Cancer Res 2008; 14: 1639–48; PMID:18347165; http://dx.doi.org/10.1158/1078-0432.CCR-07-2179
   PubMed Web of Science ®Google Scholar
• Raices M, D'Angelo MA. Nuclear pore complex composition: a new regulator of tissue-specific and developmental functions. Nat Rev Mol Cell Biol 2012; 13: 687–99; PMID:23090414; http://dx.doi.org/10.1038/nrm3461
   PubMed Web of Science ®Google Scholar
• Hashizume C, Kobayashi A, Wong RW. Down-modulation of nucleoporin RanBP2/Nup358 impaired chromosomal alignment and induced mitotic catastrophe. Cell Death Dis 2013; 4: e854; PMID:24113188; http://dx.doi.org/10.1038/cddis.2013.370
   PubMed Web of Science ®Google Scholar
• Hashizume C, Moyori A, Kobayashi A, Yamakoshi N, Endo A, Wong RW. Nucleoporin Nup62 maintains centrosome homeostasis. Cell Cycle 2013; 12: 3804–16; PMID:24107630; http://dx.doi.org/10.4161/cc.26671
   PubMed Web of Science ®Google Scholar
• Nakano H, Wang W, Hashizume C, Funasaka T, Sato H, Wong RW. Unexpected role of nucleoporins in coordination of cell cycle progression. Cell Cycle 2011; 10: 425–33; PMID:21270521; http://dx.doi.org/10.4161/cc.10.3.14721
   PubMed Web of Science ®Google Scholar
• Wong RW. Interaction between rae1 and cohesin subunit SMC1 is required for proper spindle formation. Cell Cycle 2010; 9: 198–200; PMID:20016259; http://dx.doi.org/10.4161/cc.9.1.10431
   PubMed Web of Science ®Google Scholar
• Wong RW. An update on cohesin function as a 'molecular glue' on chromosomes and spindles. Cell Cycle 2010; 9: 1754–8; PMID:20436296; http://dx.doi.org/10.4161/cc.9.9.11806
   PubMed Web of Science ®Google Scholar
• Wong RW, Blobel G. Cohesin subunit SMC1 associates with mitotic microtubules at the spindle pole. Proc Natl Acad Sci U S A 2008; 105: 15441–5; PMID:18832153; http://dx.doi.org/10.1073/pnas.0807660105
   PubMed Web of Science ®Google Scholar
• Wong RW, Blobel G, Coutavas E. Rae1 interaction with NuMA is required for bipolar spindle formation. Proc Natl Acad Sci U S A 2006; 103: 19783–7; PMID:17172455; http://dx.doi.org/10.1073/pnas.0609582104
   PubMed Web of Science ®Google Scholar
• Strambio-De-Castillia C, Niepel M, Rout MP. The nuclear pore complex: bridging nuclear transport and gene regulation. Nat Rev Mol Cell Biol 2010; 11: 490–501; PMID:20571586; http://dx.doi.org/10.1038/nrm2928
   PubMed Web of Science ®Google Scholar
• Funasaka T, Nakano H, Wu Y, Hashizume C, Gu L, Nakamura T, Wang W, Zhou P, Moore MA, Sato H, Wong RW. RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis. Cell Cycle 2011; 10:1456-67; PMID:21467841; http://dx.doi.org/10.4161/cc.10.9.15494
   PubMed Web of Science ®Google Scholar
• Hashizume C, Nakano H, Yoshida K, Wong RW. Characterization of the role of the tumor marker Nup88 in mitosis. Mol Cancer 2010; 9: 119; PMID:20497554; http://dx.doi.org/10.1186/1476-4598-9-119
   PubMed Web of Science ®Google Scholar
• Hashizume C, Wong RW. Structure and function of nuclear pore complex. Seikagaku 2011; 83: 957–65; PMID:22184889
   PubMedGoogle Scholar
• Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004; 23: 2825–37; PMID:15077146; http://dx.doi.org/10.1038/sj.onc.1207528
   PubMed Web of Science ®Google Scholar
• Ha GH, Kim HS, Lee CG, Park HY, Kim EJ, Shin HJ, Lee JC, Lee KW, Lee CW. Mitotic catastrophe is the predominant response to histone acetyltransferase depletion. Cell Death Differ 2009; 16: 483–97; PMID:19096391; http://dx.doi.org/10.1038/cdd.2008.182
   PubMed Web of Science ®Google Scholar
• David-Watine B. Silencing nuclear pore protein tpr elicits a senescent-like phenotype in cancer cells. PLoS One 2011; 6: e22423; PMID:21811608; http://dx.doi.org/10.1371/journal.pone.0022423
   PubMed Web of Science ®Google Scholar
• Jiang M, Chiu SY, Hsu W. SUMO-specific protease 2 in Mdm2-mediated regulation of p53. Cell Death Differ 2011; 18: 1005–15; PMID:21183956; http://dx.doi.org/10.1038/cdd.2010.168
   PubMed Web of Science ®Google Scholar
• Schimmel J, Eifler K, Sigurethsson JO, Cuijpers SA, Hendriks IA, Verlaan-de Vries M, Kelstrup CD, Francavilla C, Medema RH, Olsen JV., et al. Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein. Mol Cell 2014; 53: 1053–66; PMID:24582501; http://dx.doi.org/10.1016/j.molcel.2014.02.001
   PubMed Web of Science ®Google Scholar
• Liu Q, Kaneko S, Yang L, Feldman RI, Nicosia SV, Chen J, Cheng JQ. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. J Biol Chem 2004; 279: 52175–82; PMID:15469940; http://dx.doi.org/10.1074/jbc.M406802200
   PubMed Web of Science ®Google Scholar
• Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, Suzuki F, Fujii S, Arlinghaus RB, Czerniak BA, Sen S. Phosphorylation by aurora kinase a induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 2004; 36: 55–62; PMID:14702041; http://dx.doi.org/10.1038/ng1279
   PubMed Web of Science ®Google Scholar
• Nair JS, Ho AL, Schwartz GK. The induction of polyploidy or apoptosis by the aurora a kinase inhibitor MK8745 is p53-dependent. Cell Cycle 2012; 11: 807–17; PMID:22293494; http://dx.doi.org/10.4161/cc.11.4.19323
   PubMed Web of Science ®Google Scholar
• Goldenson B, Crispino JD. The aurora kinases in cell cycle and leukemia. Oncogene 2014; 34:537-45; PMID:24632603; http://dx.doi.org 10.1038/onc.2014.14
   PubMed Web of Science ®Google Scholar
• Zou Z, Yuan Z, Zhang Q, Long Z, Chen J, Tang Z, Zhu Y, Chen S, Xu J, Yan M., et al. Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells. Autophagy 2012; 8: 1798–810; PMID:23026799; http://dx.doi.org/10.4161/auto.22110
   PubMed Web of Science ®Google Scholar
• Karthigeyan D, Prasad SB, Shandilya J, Agrawal S, Kundu TK. Biology of aurora a kinase: implications in cancer manifestation and therapy. Med Res Rev 2010; 31: 757–93; PMID:20196102; http://dx.doi.org/10.4161/auto.22110
   PubMed Web of Science ®Google Scholar
• Reboutier D, Troadec MB, Cremet JY, Chauvin L, Guen V, Salaun P, Prigent C. Aurora a is involved in central spindle assembly through phosphorylation of ser 19 in P150Glued. J Cell Biol 2013; 201: 65–79; PMID:23547029; http://dx.doi.org/10.1083/jcb.201210060
   PubMed Web of Science ®Google Scholar
• Kimura M, Kotani S, Hattori T, Sumi N, Yoshioka T, Todokoro K, Okano Y. Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, aik, related to aurora of drosophila and yeast Ipl1. J Biol Chem 1997; 272: 13766–71; PMID:9153231; http://dx.doi.org/10.1074/jbc.272.21.13766
   PubMed Web of Science ®Google Scholar
• Bayliss R, Sardon T, Vernos I, Conti E. Structural basis of aurora-a activation by TPX2 at the mitotic spindle. Mol Cell 2003; 12: 851–62; PMID:14580337; http://dx.doi.org/10.1016/S1097-2765(03)00392-7
   PubMed Web of Science ®Google Scholar
• Gizatullin F, Yao Y, Kung V, Harding MW, Loda M, Shapiro GI. The aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. Cancer Res 2006; 66: 7668–77; PMID:16885368; http://dx.doi.org/10.1158/0008-5472.CAN-05-3353
   PubMed Web of Science ®Google Scholar
• Ertych N, Stolz A, Stenzinger A, Weichert W, Kaulfuss S, Burfeind P, Aigner A, Wordeman L, Bastians H. Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells. Nat Cell Biol 2014; 16: 779–91; PMID:24976383; http://dx.doi.org/10.1038/ncb2994
   PubMed Web of Science ®Google Scholar
• Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C., et al. A homologue of drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 1998; 17: 3052–65; PMID:9606188; http://dx.doi.org/10.1093/emboj/17.11.3052
   PubMed Web of Science ®Google Scholar
• Alfonso P, Canamero M, Fernandez-Carbonie F, Nunez A, Casal JI. Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling. J Proteome Res 2008; 7: 4247–55; PMID:18707159; http://dx.doi.org/10.1021/pr800152u
   PubMed Web of Science ®Google Scholar
• de Carcer G, Malumbres M. A centrosomal route for cancer genome instability. Nat Cell Biol 2014; 16: 504–6; PMID:24875738; http://dx.doi.org/10.1038/ncb2978
   PubMed Web of Science ®Google Scholar